Medpace Holdings, Inc.

Medpace Holdings, Inc.

MEDP·NASDAQ

$450.81

+1.2%
HealthcareMedical - Diagnostics & Research

Medpace Holdings, Inc. provides clinical research-based drug and medical device development services in North America, Europe, and Asia. It offers a suite of services supporting the clinical development process from Phase I to Phase IV in various therapeutic areas. The company also provides clinical development services to the pharmaceutical, biotechnology, and medical device industries; and development plan design, coordinated central laboratory, project management, regulatory affairs, clinical monitoring, data management and analysis, pharmacovigilance new drug application submissions, and post-marketing clinical support services. In addition, it offers bio-analytical laboratory services, clinical human pharmacology, imaging services, and electrocardiography reading support for clinical trials. The company was founded in 1992 and is based in Cincinnati, Ohio.

At a Glance

Live Snapshot
Market Cap$12.88B
EPS15.6400
P/E Ratio28.82
Earnings Date07/20/2026

medp

EPS

Last Annual Value

15.64

3-Year CAGR

27%

5-Year CAGR

31%

10-Year CAGR

50%

Medpace Holdings, Inc.

Medpace Holdings, Inc. Competitors Analysis of EPS

MEDP · NASDAQ
CompanyEPS
CAGR 3Y
CAGR 5Y
CAGR 10Y
15.64
19.3%25.3%45.0% 
-13.61
N/AN/AN/A
TEM logo
Tempus AI, Inc.
NASDAQ:TEM
-1.41
N/AN/AN/A
10.80
-0.2%-0.8%5.3%
8.87
5.3%-11.0%6.8%
ILMN logo
Illumina, Inc.
NASDAQ:ILMN
5.48
N/A1.5%5.7%
6.83
-5.1%-5.2%13.3%
15.61
37.5%12.8%N/A
HOLX logo
Hologic, Inc.
NASDAQ:HOLX
2.50
10.6%-19.2%7.8%
Medpace Holdings, Inc.

Medpace Holdings, Inc. Fair Value Envelope

MEDP · NASDAQ

Our analysis suggests that MEDP has a fair value of HIDDEN per share in the Base Case projection. With shares currently trading at $450.815, this represents a potential HIDDEN relative to our calculated worth for Medpace Holdings, Inc..

Intrinsic Value
Current Price: $450.815